Blog

CTNJ OP-ED | Connecticut’s Healthcare Market Regulation is Broken

By Ellen Andrews | January 17, 2022

Connecticut’s healthcare markets are consolidating at a serious clip and it’s endangering access to care and driving up healthcare prices…

Read More

New Cost Cap industry-driven committee gets going

By Ellen Andrews | January 6, 2022

Members of the Office of Health Strategy’s (OHS) latest committee to drive down the growth in Connecticut’s healthcare spending moved…

Read More

FAQs on OHS’s Primary Care Roadmap

By Ellen Andrews | January 3, 2022

Download the FAQs here Connecticut’s Office of Health Strategy has developed a Primary Care Roadmap to support primary care in…

Read More

Public comment concerns with CT’s primary care plan

By Ellen Andrews | January 1, 2022

Read the public comments Public comment concerns with CT’s primary care plan Today, the CT Health Policy Project submitted public…

Read More

Guest Blog: Why Advocacy Tools Matter by Haley Magnetta

By Ellen Andrews | December 30, 2021

You want to make a difference, but advocacy can be confusing, frustrating, and time-consuming.  We can help. Sign up for…

Read More

Book Club — You Have More Influence Than You Think

By Ellen Andrews | December 29, 2021

By Vanessa Bohns I want to send every advocate a copy of this book. You Have More Influence Than You…

Read More

Sign up for daily tips on the Art and Craft of Advocacy

By Ellen Andrews | December 14, 2021

You want to make a difference, but advocacy can be confusing, frustrating, and time-consuming. We can help. Sign up for…

Read More

Health equity state scorecard finds CT compares well, but needs improvement

By Ellen Andrews | December 13, 2021

Connecticut ranks fifth best among states on overall health equity according to the Commonwealth Fund’s latest state scorecard, but every…

Read More

ICER report on fair access to drugs prompts six insurers to change coverage policies

By Ellen Andrews | December 1, 2021

A powerful new scorecard from the Institute for Clinical and Economic Review (ICER) assessing 15 of the largest US formularies…

Read More